Next Article in Journal
4-[(3,5-Dimethyl-1H-pyrazol-1-yl)methyl]-4-methyl-2-phenyl-4,5-dihydrooxazole
Previous Article in Journal
1-(Imidazo[1,2-a]pyridin-1-ium-1-yl)-2,3,4-trioxocyclobutan-1-ide
Article Menu

Export Article

Open AccessShort Note

2,6-Bis[4-(4-butylphenyl)-1H-1,2,3-triazol-1-yl]-9-dodecyl-9H-purine

Faculty of Materials Science and Applied Chemistry, Riga Technical University, P. Valdena Str. 3, LV-1048 Riga, Latvia
*
Author to whom correspondence should be addressed.
Molbank 2019, 2019(3), M1073; https://doi.org/10.3390/M1073
Received: 21 June 2019 / Accepted: 12 July 2019 / Published: 14 July 2019
(This article belongs to the Section Organic Synthesis)
  |  
PDF [866 KB, uploaded 14 July 2019]
  |     |  

Abstract

Target 2,6-bis[4-(4-butylphenyl)-1H-1,2,3-triazol-1-yl]-9-dodecyl-9H-purine has been prepared via a Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition reaction between 2,6-diazido-9-dodecyl-9H-purine and 4-n-butyl(phenylacetylene) in a 29% yield. The obtained compound was fully characterized by NMR, IR and HRMS. View Full-Text
Keywords: purines; bis(triazolyl)purines; N(9)-alkylated purines; CuAAC purines; bis(triazolyl)purines; N(9)-alkylated purines; CuAAC
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Šišuļins, A.; Bizdēna, Ē.; Turks, M.; Novosjolova, I. 2,6-Bis[4-(4-butylphenyl)-1H-1,2,3-triazol-1-yl]-9-dodecyl-9H-purine. Molbank 2019, 2019, M1073.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molbank EISSN 1422-8599 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top